Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity
Elliot D. Kramer, Scott I. Abrams
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
Samuel I. Kim, Christopher R. Cassella, Katelyn T. Byrne
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 119
The Notch signaling pathway: a potential target for cancer immunotherapy
Xinxin Li, Xianchun Yan, Yufeng Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 79
Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
Mithunah Krishnamoorthy, Lara Gerhardt, Saman Maleki Vareki
Cells (2021) Vol. 10, Iss. 5, pp. 1170-1170
Open Access | Times Cited: 58
MYC and therapy resistance in cancer: risks and opportunities
Giulio Donati, Bruno Amati
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3828-3854
Open Access | Times Cited: 53
Neutrophils as a potential therapeutic target in Alzheimer’s disease
Michelle L. Aries, Tiffany Hensley‐McBain
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells
Brahm H. Segal, Thejaswini Giridharan, Sora Suzuki, et al.
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 13-35
Open Access | Times Cited: 32
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression
Sean Colligan, Andrea M. Amitrano, Robert Zollo, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 23
Open Access | Times Cited: 28
Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer
Sonia Ben Hamouda, Khadija Essafi‐Benkhadir
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5600-5600
Open Access | Times Cited: 20
β-Catenin signaling in alveolar macrophages enhances lung metastasis through a TNF-dependent mechanism
Elliot D. Kramer, Stephanie L. Tzetzo, Sean Colligan, et al.
JCI Insight (2023) Vol. 8, Iss. 8
Open Access | Times Cited: 17
LncRNA-targeting bio-scaffold mediates triple immune effects for postoperative colorectal cancer immunotherapy
Feng Liu, Zheng Dai, Qian Cheng, et al.
Biomaterials (2022) Vol. 284, pp. 121485-121485
Closed Access | Times Cited: 25
Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies
Khetam Sounbuli, Н. Л. Миронова, Л. А. Алексеева
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15827-15827
Open Access | Times Cited: 25
PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
Mingyu Liu, Chong Wu, Shufeng Luo, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 4
Open Access | Times Cited: 23
Neutrophils: Musketeers against immunotherapy
Kashif Rafiq Zahid, Umar Raza, Soumya Tumbath, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
The Role of the Tumor Microenvironment in Tumor Progression and Response to Therapy
Rafal Salim, Watheq Mohammed AL-Jewari
(2025) Vol. 1, Iss. 1, pp. 9-14
Closed Access
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer
Liqun Yu, Keziah Liebenberg, Yichao Shen, et al.
Immunity (2025)
Closed Access
Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments
Hossein Ghanbarian, Shahin Aghamiri, Mohamad Eftekhary, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 591-591
Open Access | Times Cited: 29
The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Gabriel Cabrera, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Nanomedicines modulating myeloid-derived suppressor cells for improving cancer immunotherapy
Xinghang Dai, Long Ren, Mengxi Liu, et al.
Nano Today (2021) Vol. 39, pp. 101163-101163
Closed Access | Times Cited: 25
Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells
Lei Wu, Xudong Liu, Juan Lei, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e008081-e008081
Open Access | Times Cited: 9
Transforming growth f actor‐beta1 and m yeloid‐derived suppressor cells: A cancerous partnership
Slavko Mojsilović, Sonja S. Mojsilović, Sunčica Kapor, et al.
Developmental Dynamics (2021) Vol. 251, Iss. 1, pp. 85-104
Open Access | Times Cited: 22
Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review
Carmen Kut, Lawrence Kleinberg
Chinese Clinical Oncology (2023) Vol. 12, Iss. 1, pp. 4-4
Open Access | Times Cited: 7
Ablative and Immunostimulatory Effects of Histotripsy Ablation in a Murine Osteosarcoma Model
Alayna N. Hay, Khan Mohammad Imran, Alissa Hendricks-Wenger, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2737-2737
Open Access | Times Cited: 7
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
Mattia Emanuela Ligotti, Fanny Pojero, Giulia Accardi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
CD73 expression in myeloid-derived suppressor cells is correlated with clinical stages in head and neck squamous cell carcinomas
Weihui Zheng, Ying Zhu, Xiaolong Chen, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 14, pp. 1148-1148
Open Access | Times Cited: 13
The Voltage-Gated Hv1 H+ Channel Is Expressed in Tumor-Infiltrating Myeloid-Derived Suppressor Cells
Marco Cozzolino, Adrienn Gyöngyösi, Éva Korpos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6216-6216
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top